Literature DB >> 18083273

Comparison of histopathologic-clinical characteristics of Jessner's lymphocytic infiltration of the skin and lupus erythematosus tumidus: Multicenter study of 46 cases.

Valérie Rémy-Leroux1, Fabienne Léonard, Daniel Lambert, Janine Wechsler, Bernard Cribier, Pierre Thomas, Henri Adamski, Marie-Claude Marguery, François Aubin, Dominique Leroy, Philippe Bernard.   

Abstract

OBJECTIVE: We sought to identify criteria able to distinguish between Jessner's lymphocytic infiltration of the skin (JLIS) and lupus erythematosus tumidus (LET).
METHODS: The following characteristics were recorded in a retrospective, multicenter analysis of patients with JLIS and LET: clinical features (number, size, type, and localization of lesions; photosensitivity; extracutaneous signs), histologic findings, phototesting, lupus serology, treatment, and outcome. Available histologic slides were reviewed blinded to the initial diagnosis using a pre-established grid.
RESULTS: Univariate analysis of data from patients with JLIS (15 women, 17 men; mean age: 35 years) and LET (13 women, one man; mean age: 31 years) showed the following significant (P < .05) differences: more frequent back involvement and annular lesions in JLIS, as opposed to female predominance, more frequent face involvement, and plaques in LET. Phototesting, especially ultraviolet B, induced lesions in 18 of 26 patients with JLIS and all 4 with LET. The blinded histologic review (33 samples) only found slight epidermal atrophy and focal thickened dermoepidermal junction more frequent and perivascular lymphocyte infiltrations less dense in LET. The two groups of patients reclassified according histopathologic features (18 LET and 11 JLIS) showed only slight clinical differences (more frequent nasal bridge lesions in LET and annular lesions in JLIS). LIMITATION: The retrospective nature of the study is a limitation.
CONCLUSION: JLIS and LET in this population showed more similarities than differences, supporting a continuous spectrum covering these two entities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083273     DOI: 10.1016/j.jaad.2007.09.039

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

Review 1.  The Cutaneous Spectrum of Lupus Erythematosus.

Authors:  Simone Ribero; Savino Sciascia; Luca Borradori; Dan Lipsker
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 2.  [Dermatological symptoms in rheumatology].

Authors:  E Aberer
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

3.  Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem.

Authors:  Ilko Bakardzhiev; Anastasiya Atanasova Chokoeva; Ivan Krasnaliev; Claudio Tana; Uwe Wollina; Torello Lotti; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2016-01-13

4.  Possibly drug-induced palpable migratory arciform erythema.

Authors:  Fernando Luiz Teixeira Dantas; Neusa Yuriko Sakai Valente; Isis Suga Veronez; Priscila Kakizaki; Juliana Ribeiro Leitão; Rafael Cavanellas Fraga
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

5.  Lupus erythematosus tumidus: clinical perspectives.

Authors:  Nikolaos Patsinakidis; Ocko Kautz; Bernhard F Gibbs; Ulrike Raap
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-01

Review 6.  Dermatological Considerations in the Diagnosis and Treatment of Marginal Zone Lymphomas.

Authors:  Andrea Ronchi; Antonello Sica; Paola Vitiello; Renato Franco
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-03-08

7.  Chilblains in immune mediated inflammatory diseases: a review.

Authors:  Shirish Dubey; Nilay Joshi; Olivia Stevenson; Caroline Gordon; John A Reynolds
Journal:  Rheumatology (Oxford)       Date:  2022-04-12       Impact factor: 7.046

8.  Tumid lupus erythematosus: an intriguing dermatopathological connotation treated successfully with topical tacrolimus and hydroxyxhloroquine combination.

Authors:  Prashant Verma; Sonal Sharma; Pravesh Yadav; Chaitanya Namdeo; Garima Mahajan
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

9.  A 23-Year-Old Man with Hyper-IgM Syndrome Presenting with Asymptomatic Violaceous Facial Plaques.

Authors:  Mirelys Barrios; Neera Nathan; Ryan Trowbridge; Molly Plovanich; Rosalynn M Nazarian; Daniela Kroshinsky
Journal:  Dermatopathology (Basel)       Date:  2020-01-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.